NCT03007238View on ClinicalTrials.gov

Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 18, 2017

Primary Completion Date

October 16, 2018

Study Completion Date

June 26, 2019

Conditions
Chronic Graft Versus Host Disease
Interventions
BIOLOGICAL

Aldesleukin

Given SC

PROCEDURE

Extracorporeal Photopheresis

Undergo ECP

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT03007238 - Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease | Biotech Hunter | Biotech Hunter